Anemia in chronic kidney disease and its cardiovascular implications;Anemia en la insuficiencia renal crónica y sus implicaciones cardiovasculares

Medicina Clinica

Volumn 132, Issue SUPPL. 1, 2009, Pages 38-42

  Cases, A ^a,d   Coll, E ^b   Collado, S ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Anemia; Cardiovascular risk; Chronic kidney disease; Left ventricular hypertrophy

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; DISEASE COURSE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; PLEIOTROPY; PRACTICE GUIDELINE; QUALITY OF LIFE;

ANEMIA; CARDIOVASCULAR DISEASES; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 67649130992     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/s0025-7753(09)70961-3     Document Type: Article

References (54)

1. D.S. Keith, G.A. Nichols, C.M. Gullion, J.B. Brown, and D.H. Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663 (Pubitemid 38392981)
2. R.N. Foley, A.M. Murray, S. Li, C.A. Herzog, A.M. McBean, and P.W. Eggers Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 J Am Soc Nephrol 16 2005 489 495 (Pubitemid 41725146)
3. S.I. Hallan, K. Dahl, C.M. Oien, D.C. Grootendorst, A. Aasberg, and J. Holmen Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey BMJ 333 2006 1047 1050 (Pubitemid 44807817)
4. A. Levin Prevalence of cardiovascular damage in early renal disease Nephrol Dial Transplant 16 Suppl 2 2001 7 11 (Pubitemid 32479547)
5. B.C. Astor, P. Muntner, A. Levin, J.A. Eustace, and J. Coresh Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 162 2002 1401 1408 (Pubitemid 34655201)
6. S. Thomas, and M. Rampersad Anaemia in diabetes Acta Diabetologica 41 Suppl 1 2004 S13 S17
7. M. Nangaku, and K.U. Eckardt Pathogenesis of renal anemia Semin Nephrol 26 2006 261 268 (Pubitemid 44722454)
8. K.U. Eckardt Cardiovascular consequences of renal anemia and erythropoietin therapy Nephrol Dial Transplant 14 1999 1317 1323
9. J.S. Anand, Y. Chandrashekhar, R. Ferrari, P.A. Poole-Wilson, and P.C. Harris Pathogenesis of oedema in chronic severe anemia: Studies on body water, and sodium, renal function, hemodynamic variables, and plasma hormones Br Heart J 70 1997 357 362 (Pubitemid 23309546)
10. F. Metivier, S.J. Marchais, A.P. Guerin, B. Pannier, and G.M. London Pathophysiology of anemia: focus on the heart and blood vessels Nephrol Dial Transplant 15 Supl 39 2000 S15 S18
11. W. Siems, F. Carluccio, S. Radenkovic, T. Grune, and H. Hampl Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment Kidney Blood Press Res 28 2005 295 301
12. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray, and P.E. Barre The impact of anemia on cardiomyopathy, morbidity, and mortality in endstage renal disease Am J Kidney Dis 28 1996 53 61 (Pubitemid 26231466)
13. R.N. Foley, P.S. Parfrey, G.M. Kent, J.D. Harnett, D.C. Murray, and P.E. Barre Long-term evolution of cardiomyopathy in dialysis patients Kidney Int 54 1998 1720 1725 (Pubitemid 28502916)
14. A. Levin, C.R. Thompson, J. Ethier, E.J. Carlisle, S. Tobe, and D. Mendelssohn Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 1999 125 134 (Pubitemid 29318806)
15. D.C. Holland, and M. Lam Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study Nephrol Dial Transplant 15 2000 650 658 (Pubitemid 30242983)
16. C.P. Kovesdy, B.K. Trivedi, K. Kalantar-Zadeh, and J.E. Anderson Association of anemia with outcomes in men with moderate and severe chronic kidney disease Kidney Int 69 2006 560 564 (Pubitemid 43164450)
17. A. Levin, O. Djurdjev, J. Duncan, D. Rosenbaum, and R. Werb Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes Nephrol Dial Transplant 21 2006 370 377 (Pubitemid 43159990)
18. P.T. Vlagopoulos, H. Tighiouart, D.E. Weiner, J. Griffith, D. Pettitt, and D.N. Salem Anemia as a risk factor for cardiovascular disease and allcause mortality in diabetes: the impact of chronic kidney disease J Am Soc Nephrol 16 2005 3403 3410 (Pubitemid 46179344)
19. P.A. McCullough, C.T. Jurkovitz, P.E. Pergola, J.B. McGill, W.W. Brown, and A.J. Collins Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP) Arch Intern Med 167 2007 1122 1129 (Pubitemid 46919814)
20. P. Muntner, J. He, B.C. Astor, A.R. Folsom, and J. Coresh Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study J Am Soc Nephrol 16 2005 529 538 (Pubitemid 41725151)
21. J.L. Abramson, C.T. Jurkovitz, V. Vaccarino, W.S. Weintraub, and W. McClellan Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study Kidney Int 64 2003 610 615 (Pubitemid 36871933)
22. B.C. Astor, J. Coresh, G. Heiss, D. Pettitt, and M.J. Sarnak Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study Am Heart J 151 2006 492 500 (Pubitemid 43144756)
23. H.S. Gurm, A.M. Lincoff, N.S. Kleiman, D.J. Kereiakes, J.E. Tcheng, and H.D. Aronow Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions Am J Cardiol 94 2004 30 34 (Pubitemid 38813449)
24. T.M. Keough-Ryan, B.A. Kiberd, C.S. Dipchaud, J.L. Cox, C.L. Rose, and K.J. Thompson Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia Am J Kidney Dis 46 2005 845 855 (Pubitemid 41505458)
25. J.R. Cook, K. Sullivan Dillie, A. Hakeem, S. Bhatti, and S. Min Chang Effectiveness of anemia and chronic kidney disease as predictors for presence and severity of coronary artery disease in patients undergoing stress myocardial perfusion study Am J Cardiol 102 2008 266 271
26. D.E. Weiner, H. Tighiouart, P.T. Vlagopoulos, J.L. Griffith, D.N. Salem, and A.S. Levey Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease J Am Soc Nephrol 16 2005 1803
27. J.W. Adamson, and J.W. Esbach Management of anemia of chronic renal failure with recombinant erithropoietin Quart J Med 73 1989 1093 1101 (Pubitemid 20019603)
28. J. Portoles, A. Torralbo, P. Martin, J. Rodrigo, J.A. Herrero, and A. Barrientos Cardiovascular effects of recombinant human erythropoietin in predialysis patients Am J Kidney Dis 29 1997 541 548 (Pubitemid 27155274)
29. T. Hayashi, A. Suzuki, T. Shoji, M. Togawa, N. Okada, and Y. Tsubakihara Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients Am J Kidney Dis 35 2000 250 256 (Pubitemid 30070847)
30. J.C. Ayus, A.S. Go, F. Valderrabano, E. Verde, S. De Vinuesa, and S.G. Achinger Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin less than 10 g/dL Kidney Int 68 2005 788 795 (Pubitemid 43323135)
31. M. Jones, B. Schenkel, and J. Just Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality Int J Cardiol 100 2005 253 263
32. S.D. Roger, L.P. McMahon, A. Clarkson, A. Disney, D. Harris, and C. Hawley Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial J Am Soc Nephrol 15 2004 148 156 (Pubitemid 38020706)
33. A. Levin, O. Djurdjev, C. Thompson, B. Barrett, J. Ethier, and E. Carlisle Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD Am J Kidney Dis 46 2005 799 811 (Pubitemid 41505453)
34. I.C. Macdougall, R.M. Temple, and J.T. Kwan Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial Nephrol Dial Transplant 22 2007 684 686
35. T. Drueke, F. Locatelli, N. Clyne, K.U. Eckardt, I.C. Macdougall, and D. Tsakiris Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 2006 2071 2084 (Pubitemid 44749316)
36. E. Ritz, M. Laville, R.W. Bilous, D. O'Donoghue, A. Scherhag, and U. Burguer Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study Am J Kidney Dis 49 2007 194 207 (Pubitemid 46178405)
37. J. Rossert, A. Levin, S.D. Roger, W. Hörl, B. Fouqueray, and C. Gassman-Maier Effect of early correction of anemia on the progression of CKD Am J Kidney Dis 47 2006 738 750
38. H. Furuland, T. Linde, J. Ahlmen, A. Christensson, U. Strombom, and B.G. Danielson A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients Nephrol Dial Transplant 18 2003 353 361 (Pubitemid 36181688)
39. A. Singh, L. Schzech, K.L. Tang, H. Barnhart, S. Sapp, and M. Wolfson Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 2006 2085 2098 (Pubitemid 44749317)
40. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50:471-530.
41. D.L. Dries, D.V. Exner, M.J. Domanski, B. Greenberg, and L.W. Stevenson The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689 (Pubitemid 30167025)
42. H.L. Hillege, A.R. Girbes, P.J. De Kam, F. Boomsma, D. De Zeeuw, and A. Charlesworth Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210 (Pubitemid 30451778)
43. A. Al-Ahmad, W.M. Rand, G. Manjunath, M.A. Konstam, D.N. Salem, and A.S. Levey Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction J Am Coll Cardiol 38 2001 955 962 (Pubitemid 32912694)
44. A.S. Go, J. Yang, L.M. Ackerson, K. Lepper, S. Robbins, and B.M. Massie Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study Circulation 113 2006 2713 2723 (Pubitemid 43947989)
45. D.S. Silverberg, D. Wexler, D. Sheps, M. Blum, G. Keren, and R. Baruk The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study J Am Coll Cardiol 37 2001 1775 1780 (Pubitemid 32499958)
46. D.S. Silverberg, D. Wexler, M. Blum, J.Z. Tchebiner, D. Sheps, and G. Keren The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron Nephrol Dial Transplant 18 2003 141 146 (Pubitemid 36104490)
47. D.S. Silverberg, D. Wexler, M. Blum, G. Keren, D. Sheps, and L. Leibovitz The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalisations J Am Coll Cardiol 35 2000 1737 1744 (Pubitemid 30342851)
48. D.S. Silverberg, D. Wexler, M. Blum, D. Schwartz, G. Keren, and D. Sheps Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians Isr Med Assoc J 5 2003 337 339 (Pubitemid 36681862)
49. A. Palazzuoli, D.S. Silberberg, F. Iovine, A. Calabró, M.S. Campagna, and M. Gallotta Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome Am Heart J 154 2007 645.e9 645.e15
50. J.E. Toblli, A. Lombraña, P. Duarte, and F. Di Gennaro Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency J Am Coll Cardiol 50 2007 1657 1665 (Pubitemid 47562670)
51. K.E. Jie, M.C. Verhaar, M.J. Cramer, K. Van der Putten, C.A. Gaillard, and P.A. Doevendans Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors Am J Physiol Renal Physiol 291 2006 F932 F944
52. M. Arcasoy The non-haematopoietic biological effects of erythropoietin Br J Haematol 141 2008 14 31 (Pubitemid 351347536)
53. L.A. Sczech, H.X. Barnhart, J.K. Insig, D.N. Reddan, S. Sapps, and R.M. Califf Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes Kidney Int 74 2008 791 798
54. E. Braunwald Heart disease: a textbook of cardiovascular medicina 5th ed. 1997 Saunders Philadelphia